Can Lamina Cribrosa Indicate Optic Neuritis in Multiple Sclerosis? Dr. Krishna Shah18 March 2023 9:45 AM ISTIn a recent article published in Neurology India, Researchers in Turkey have found that the lamina cribrosa was thinner in Multiple Sclerosis patients...
Natco Pharma rolls out additional strengths for generic version of Revlimid in US Ruchika Sharma10 March 2023 2:15 PM ISTLenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Cancer drug: Aurobindo Pharma arm Eugia Pharma gets USFDA approval for Lenalidomide Capsules Ruchika Sharma9 March 2023 1:15 PM ISTThe approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone.
Multiple Myeloma medicine: Natco Pharma unveils Pomalidomide under brand NAT-POMALIDOMIDE in Canada Ruchika Sharma1 March 2023 12:15 PM ISTMultiple myeloma, commonly referred to as myeloma, is a cancer of plasma cells.
USFDA grants priority review to Pfizer Elranatamab for relapsed or refractory multiple myeloma Ruchika Sharma24 Feb 2023 2:30 PM ISTElranatamab is an investigational, off-the-shelf, humanized BCMA CD3-targeted BsAb.
Roche gets CDCSO panel nod to market multiple sclerosis drug Ocrelizumab Dr. Divya Colin26 Jan 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Roche has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Control...
Multiple myeloma drug case: Dr Reddy Labs gets legal respite in US Ruchika Sharma29 Dec 2022 4:30 PM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories has announced that all claims against it in the antitrust litigation filed in the US, related to a...
Janssen seeks USFDA nod for Multiple myeloma treatment Talquetamab Ruchika Sharma11 Dec 2022 1:00 PM ISTRaritan, N.J.: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Biologics License Application...
Shared Monopoly in sale of generic Revlimid: Dr Reddy's Labs, Bristol Myers Squibb and others face anti-trust litigation in US Ruchika Sharma23 Nov 2022 11:52 AM ISTThe company said the complaint "alleges that the challenged agreements improperly delayed generic entry entirely until 2022 and then improperly...
GSK to withdraw blood cancer drug Blenrep from US market Ruchika Sharma22 Nov 2022 4:15 PM ISTGSK said access to Blenrep in other countries where it is marketed is unaffected, including across the European Union.
Natco Pharma unveils first generic version of Pomalyst capsules in Australia Ruchika Sharma9 Nov 2022 4:01 PM ISTPomalidomide is prescribed for treatment of Multiple Myeloma and Kaposi Sarcoma.
Setback: GSK blood cancer drug Blenrep fails main goal of superiority trial Ruchika Sharma8 Nov 2022 12:30 PM ISTBlenrep is an antibody drug conjugate comprising a humanised BCMA monoclonal antibody conjugated to the cytotoxic agent auristatin F via non-cleavable...
